NBE-002 in Patients With Advanced Solid Tumors
NCT04441099
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class
Stopped
End of Program
Conditions
Advanced Solid Tumor
Advanced Cancer
Triple Negative Breast Cancer
Interventions
DRUG:
NBE-002
Sponsor
NBE-Therapeutics AG
Collaborators
[object Object]